Paysign Inc (PAYS)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Paysign Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 13 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 9.00 $ — 95% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
NeutralIn den letzten 4 Quartalsberichten und 2 Jahresberichten von PaySign findet sich kein wesentlicher KI-Bezug — die einzige Erwähnung von „artificial intelligence“ ist ein generischer Risikofaktor in beiden 10-Ks („Our ability to adapt our existing products and services to use artificial intelligence (‚AI‘) could adversely impact our business“ — es geht dort um regulatorische Unsicherheit rund um KI-Gesetze, nicht um eine konkrete Disruptionsgefahr für das Prepaid-/Payment-Geschäft), die vier 10-Qs enthalten gar keine KI-Erwähnung; weder KI-Umsatzquelle noch belegter operativer Einsatz noch konkretes Geschäftsrisiko.
View the full file — quotes, sources, reviewed filings
Filings Reviewed: 10-Q 2026-05-13 · 10-Q 2025-11-13 · 10-Q 2025-08-06 · 10-Q 2025-05-09 · 10-K 2026-03-25 · 10-K 2025-03-26
Rated on July 9, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 10.6% above the current price.
- Consensus
- Strong Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.33 | 0.24 – 0.43 | 109 | 153.9% | 3 |
| 12/31/2027 | 0.44 | 0.38 – 0.54 | 125 | 32.3% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.14 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2023: Q2 | 0.00 | – | 11 | 27.90 | -0.90 | -3 | -5 |
| 2023: Q3 | 0.02 | 0.00 | 12 | 17.00 | 8.90 | 4 | 2 |
| 2023: Q4 | 0.10 | 900.00 | 14 | 29.20 | 40.90 | 23 | 21 |
| 2024: Q1 | 0.01 | – | 13 | 30.70 | 2.30 | 8 | 6 |
| 2024: Q2 | 0.01 | – | 14 | 30.00 | 4.90 | 21 | 18 |
| 2024: Q3 | 0.03 | 50.00 | 15 | 23.40 | 9.20 | -20 | -23 |
| 2024: Q4 | 0.02 | -76.40 | 16 | 14.00 | 8.80 | 14 | 12 |
| 2025: Q1 | 0.05 | 731.10 | 19 | 41.00 | 13.90 | -6 | -9 |
| 2025: Q2 | 0.02 | 92.20 | 19 | 33.10 | 7.30 | 4 | 2 |
| 2025: Q3 | 0.04 | 39.90 | 22 | 41.60 | 10.30 | 7 | 5 |
| 2025: Q4 | 0.02 | -10.50 | 23 | 45.80 | 6.00 | 48 | 46 |
| 2026: Q1 | 0.09 | 90.10 | 28 | 50.80 | 19.40 | 19 | 17 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 10 | 1 | 1 | 0.03 | 1 | 3 | 14 |
| 2017 | 15 | 2 | 2 | 0.04 | 7 | 5 | 20 |
| 2018 | 23 | 2 | 3 | 0.05 | 16 | 9 | 36 |
| 2019 | 35 | 6 | 7 | 0.14 | 10 | 19 | 54 |
| 2020 | 24 | -8 | -9 | -0.19 | 14 | 13 | 68 |
| 2021 | 29 | -3 | -3 | -0.05 | 15 | 13 | 84 |
| 2022 | 38 | 0 | 1 | 0.02 | 25 | 16 | 108 |
| 2023 | 47 | 0 | 6 | 0.12 | 28 | 24 | 147 |
| 2024 | 58 | 1 | 4 | 0.07 | 23 | 30 | 179 |
| 2025 | 82 | 7 | 8 | 0.13 | 52 | 48 | 276 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Paysign, Inc. bietet Prepaid-Kartenprogramme, Patientenkostenlösungen, Digital Banking, Life-Science-Softwaretechnologielösungen und integrierte Zahlungsabwicklungsdienstleistungen für Unternehmen, Verbraucher und staatliche Einrichtungen in den USA an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 226 |
| Headquarters | Henderson, NV |
| Address | 2615 St. Rose Parkway, 89052 Henderson, United States |
| Phone | 702 453 2221 |
| Website | paysign.com |
| IPO Date | 2. Apr 1998 |
| ISIN | US70451A1043 |
| Stock Split | 1:20 on 12/30/2005 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Mark R. Newcomer | Co-Founder, President, CEO & Director | 1965 |
| Matthew Turner | President of Patient Affordability | – |
| Michael Ngo | Chief Innovation Officer | – |
| Jeffery B. Baker | CFO & Treasurer | 1972 |
| Cosimo Cambi | Chief Operating Officer | – |
| Brad Cunningham | Chief Technology Officer | – |
| Eric Trudeau | Chief Compliance Officer | – |
| Robert P. Strobo Esq. | General Counsel, Chief Legal Officer & Corporate Secretary | 1980 |
| Dennis M. DiVenuta J.D. | Executive Vice President of Strategy & Corporate Development | – |
| Alicia Ches | Vice President of Marketing | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Newcomer Mark | CEO | Sell | 50,000 | 9.38 | 468,985 |
| 16. Jul 2026 | Herman Joan M | EVP, Operations | Sell | 28,000 | 8.69 | 243,410 |
| 15. Jul 2026 | Herman Joan M | EVP, Operations | Sell | 31,904 | 8.60 | 274,253 |
| 11. Jun 2026 | Mina Bruce A | Director | Sell | 10,000 | 7.10 | 70,950 |
| 1. Jun 2026 | Mina Bruce A | Director | Sell | 10,000 | 7.10 | 71,000 |
| 8. May 2026 | Triplett Dennis L | Director | Other | 20,000 | 0.00 | – |
| 8. May 2026 | Newman Jeffrey B | Director | Other | 20,000 | 0.00 | – |
| 8. May 2026 | Mina Bruce A | Director | Other | 20,000 | 0.00 | – |
| 8. May 2026 | Henry Daniel R | Director | Other | 20,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.